STEVENS JENNIFER (Chief Regulatory Officer) sold 10.1% of their position (8.70K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market sale worth $45.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/21/2025ACC: 0001826667-25-000053
Officer· Chief Regulatory Officer
Since Aug 2023
+19.75K
Net shares
Net buyer
$45.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
28.45K acquired · 8.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28.45K
Price / share
$5.18
Trade value
$147.40K
% of position
49.2%
5/19/2025
57.89K→86.34K
Common Stock
Direct
Shares
−8.70K
Price / share
$5.18
Trade value
$45.09K
% of position
10.1%
5/19/2025
86.34K→77.64K
Total
Net shares
+19.75K
Net value
$102.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2025 | A · Award | +28.45K | $5.18 | $147.40K | 49.2% | 57.89K | 86.34K |
| Common Stock Direct | 5/19/2025 | S · Sale | −8.70K | $5.18 | $45.09K | 10.1% | 86.34K | 77.64K |
| Total | +19.75K | $102.31K | ||||||
Derivative Transactions0
No derivative transactions reported